Soo-Taek Uh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Soo-Taek Uh has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Choon-Sik Park
Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
8 shared publications Yang-Ki Kim
Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, Korea
8 shared publicationsKi-Up Kim
Division of Respiratory and Allergy Medicine, Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, Korea
7 shared publications- Young Mok Lee
GF Allergy Clinic, Seoul, Korea
7 shared publications Ki Up Kim
Department of Respiratory and Allergy Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
5 shared publicationsYong Hoon Kim
Department of Respiratory and Allergy Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea
5 shared publications
Latest Publications
- 1 September 2012
- Published by Wolters Kluwer Health in Diagnostic Molecular Pathology
- Vol. 21  (3) , 164-171
Potential Association Between ANXA4 Polymorphisms and Aspirin-exacerbated Respiratory Disease
Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by bronchoconstriction after ingestion of nonsteroidal anti-inflammatory drugs including aspirin. The Ca concentration in bronchial epithelial cells is an important factor for bronchoconstriction. Human annexin A4 (ANXA4) is predominantly expressed in the secretory epithelia in the lung, stomach, intestine, and kidney. Furthermore, translocation and induction of ANXA4 have been observed in human Ca-depleted neutrophils. To investigate the association between annexin A4 polymorphisms and the risk of AERD, we have genotyped 21 variants from 102 AERD subjects and 429 aspirin-tolerant asthma (ATA) controls. Logistic analyses controlling for sex, smoking status, and atopy as covariates were performed to estimate the association between the annexin A4 polymorphisms and AERD. Among these variants, 8 polymorphisms (rs2168116, rs4853017, rs6546547, rs13428251, rs7577864, rs7559354, rs7588022, and rs3816491) and 2 haplotypes (ANXA4-ht3 and ANXA4-ht5) were significantly associated with the risk of AERD. One common polymorphism in intron 11, rs3816491, showed the strongest association signal with susceptibility to aspirin-AERD even after multiple testing corrections (OR=0.57; 95% confidence interval 0.40-0.83; P=0.003; P=0.045 in the codominant model). Although further functional evaluations of replication studies in larger cohorts are required, our findings suggest that the annexin A4 could have susceptibility for AERD.
- 1 September 2012
- Published by Wolters Kluwer Health in Diagnostic Molecular Pathology
- Vol. 21  (3) , 164-171
Potential Association Between ANXA4 Polymorphisms and Aspirin-exacerbated Respiratory Disease
Aspirin-exacerbated respiratory disease (AERD) is a clinical syndrome characterized by bronchoconstriction after ingestion of nonsteroidal anti-inflammatory drugs including aspirin. The Ca concentration in bronchial epithelial cells is an important factor for bronchoconstriction. Human annexin A4 (ANXA4) is predominantly expressed in the secretory epithelia in the lung, stomach, intestine, and kidney. Furthermore, translocation and induction of ANXA4 have been observed in human Ca-depleted neutrophils. To investigate the association between annexin A4 polymorphisms and the risk of AERD, we have genotyped 21 variants from 102 AERD subjects and 429 aspirin-tolerant asthma (ATA) controls. Logistic analyses controlling for sex, smoking status, and atopy as covariates were performed to estimate the association between the annexin A4 polymorphisms and AERD. Among these variants, 8 polymorphisms (rs2168116, rs4853017, rs6546547, rs13428251, rs7577864, rs7559354, rs7588022, and rs3816491) and 2 haplotypes (ANXA4-ht3 and ANXA4-ht5) were significantly associated with the risk of AERD. One common polymorphism in intron 11, rs3816491, showed the strongest association signal with susceptibility to aspirin-AERD even after multiple testing corrections (OR=0.57; 95% confidence interval 0.40-0.83; P=0.003; P=0.045 in the codominant model). Although further functional evaluations of replication studies in larger cohorts are required, our findings suggest that the annexin A4 could have susceptibility for AERD.
- Open Access
- 4 January 2012
- Published by Springer Nature in BMC Medical Genetics
- Vol. 13  (1) , 2
Possible role of EMID2 on nasal polyps pathogenesis in Korean asthma patients
Background: Since subepithelial fibrosis and protruded extracellular matrix are among the histological characteristics of polyps, the emilin/multimerin domain-containing protein 2 (EMID2) gene is speculated to be involved in the presence of nasal polyps in asthma and aspirin-hypersensitive patients. Methods: To investigate the association between EMID2 and nasal polyposis, 49 single-nucleotide polymorphisms (SNPs) were genotyped in 467 asthmatics of Korean ancestry who were stratified further into 114 aspirin exacerbated respiratory disease (AERD) and 353 aspirin-tolerant asthma (ATA) subgroups. From pairwise comparison of the genotyped polymorphisms, 14 major haplotypes (frequency > 0.05) were inferred and selected for association analysis. Differences in the frequency distribution of EMID2 variations between polyp-positive cases and polyp-negative controls were determined using logistic analyses. Results: Initially, 13 EMID2 variants were significantly associated with the presence of nasal polyps in the overall asthma group (P = 0.0008-0.05, OR = 0.54-1.32 using various modes of genetic inheritance). Although association signals from 12 variants disappeared after multiple testing corrections, the relationship between EMID2_BL1_ht2 and nasal polyposis remained significant via a codominant mechanism (P corr = 0.03). On the other hand, the nominal associations observed between the genetic variants tested for the presence of nasal polyps in AERD (P = 0.003-0.05, OR = 0.25-1.82) and ATA (P = 0.01-0.04, OR = 0.46-10.96) subgroups disappeared after multiple comparisons, suggesting lack of associations. Conclusions: These preliminary findings suggest that EMID2_BL1_ht2 may be a susceptibility marker of inflammation of the nasal passages among Korean asthma patients.
- 4 January 2012
- Published by Springer Nature in BMC Medical Genetics
- Vol. 13  (1) , 2
Open AccessPossible role of EMID2 on nasal polyps pathogenesis in Korean asthma patients
Background: Since subepithelial fibrosis and protruded extracellular matrix are among the histological characteristics of polyps, the emilin/multimerin domain-containing protein 2 (EMID2) gene is speculated to be involved in the presence of nasal polyps in asthma and aspirin-hypersensitive patients. Methods: To investigate the association between EMID2 and nasal polyposis, 49 single-nucleotide polymorphisms (SNPs) were genotyped in 467 asthmatics of Korean ancestry who were stratified further into 114 aspirin exacerbated respiratory disease (AERD) and 353 aspirin-tolerant asthma (ATA) subgroups. From pairwise comparison of the genotyped polymorphisms, 14 major haplotypes (frequency > 0.05) were inferred and selected for association analysis. Differences in the frequency distribution of EMID2 variations between polyp-positive cases and polyp-negative controls were determined using logistic analyses. Results: Initially, 13 EMID2 variants were significantly associated with the presence of nasal polyps in the overall asthma group (P = 0.0008-0.05, OR = 0.54-1.32 using various modes of genetic inheritance). Although association signals from 12 variants disappeared after multiple testing corrections, the relationship between EMID2_BL1_ht2 and nasal polyposis remained significant via a codominant mechanism (P corr = 0.03). On the other hand, the nominal associations observed between the genetic variants tested for the presence of nasal polyps in AERD (P = 0.003-0.05, OR = 0.25-1.82) and ATA (P = 0.01-0.04, OR = 0.46-10.96) subgroups disappeared after multiple comparisons, suggesting lack of associations. Conclusions: These preliminary findings suggest that EMID2_BL1_ht2 may be a susceptibility marker of inflammation of the nasal passages among Korean asthma patients.
- Open Access
- 1 January 2011
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 70  (1) , 74-78
A Case of Pleural Metastasis 6 Years after Complete Surgical Resection of Invasive Thymoma
Woo KJ, et al. Tuberc Respir Dis. 2011 Jan;70(1):74-78. https://doi.org/10.4046/trd.2011.70.1.74
- 1 January 2011
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 70  (1) , 74-78
Open AccessA Case of Pleural Metastasis 6 Years after Complete Surgical Resection of Invasive Thymoma
Woo KJ, et al. Tuberc Respir Dis. 2011 Jan;70(1):74-78. https://doi.org/10.4046/trd.2011.70.1.74
- Open Access
- 23 September 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11  (1) , 138
Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population
Background: Aspirin-intolerant asthma (AIA) occurs in the lower and upper airways through excessive production of leukotrienes upon administration of non-steroidal anti-inflammatory drugs (NSAIDs). One of the three symptoms of AIA is nasal polyposis, a chronic inflammatory disease that is related to the function of calcium ion in recruitment of immune cells during airway inflammation. It has been implicated that bronchodilation in the airway is related to Ca(2+) regulation. The calcium channel, voltage-dependent, gamma subunit 6 (CACNG6) gene encodes a protein that stabilizes the calcium channel. Methods: To study the associations between AIA and polymorphisms in CACNG6 gene, eight variants were genotyped in 102 AIA cases and 429 aspirin-tolerant asthma (ATA) controls. Logistic analyses were used to evaluate the associations of CACNG6 polymorphisms with AIA. Results: Statistical analyses revealed that a single nucleotide polymorphism (SNP; rs192808C > T; P = 0.0004, P corr = 0.0029, OR = 2.88 in co-dominant model; P = 0.0005, P corr = 0.0036, OR = 2.99 in dominant model) in intron and a haplotype unique to this variant (CACNG6_BL1_ht6; P = 0.003, P corr = 0.02, OR = 2.57 in co-dominant model, P = 0.001, P corr = 0.0087, OR = 2.81 in dominant model) were significantly associated with the risk of AIA. Conclusions: Our results suggest that the CACNG6 variants might be associated with the risk of AIA in a Korean population.
- 23 September 2010
- Published by Springer Nature in BMC Medical Genetics
- Vol. 11  (1) , 138
Open AccessAssociation of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population
Background: Aspirin-intolerant asthma (AIA) occurs in the lower and upper airways through excessive production of leukotrienes upon administration of non-steroidal anti-inflammatory drugs (NSAIDs). One of the three symptoms of AIA is nasal polyposis, a chronic inflammatory disease that is related to the function of calcium ion in recruitment of immune cells during airway inflammation. It has been implicated that bronchodilation in the airway is related to Ca(2+) regulation. The calcium channel, voltage-dependent, gamma subunit 6 (CACNG6) gene encodes a protein that stabilizes the calcium channel. Methods: To study the associations between AIA and polymorphisms in CACNG6 gene, eight variants were genotyped in 102 AIA cases and 429 aspirin-tolerant asthma (ATA) controls. Logistic analyses were used to evaluate the associations of CACNG6 polymorphisms with AIA. Results: Statistical analyses revealed that a single nucleotide polymorphism (SNP; rs192808C > T; P = 0.0004, P corr = 0.0029, OR = 2.88 in co-dominant model; P = 0.0005, P corr = 0.0036, OR = 2.99 in dominant model) in intron and a haplotype unique to this variant (CACNG6_BL1_ht6; P = 0.003, P corr = 0.02, OR = 2.57 in co-dominant model, P = 0.001, P corr = 0.0087, OR = 2.81 in dominant model) were significantly associated with the risk of AIA. Conclusions: Our results suggest that the CACNG6 variants might be associated with the risk of AIA in a Korean population.
- Open Access
- 1 June 2010
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 10  (1) , 34
Positive Association between Aspirin-Intolerant Asthma and Genetic Polymorphisms of FSIP1: a Case-Case Study
Background: Aspirin-intolerant asthma (AIA), which is caused by non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, causes lung inflammation and reversal bronchi reduction, leading to difficulty in breathing. Aspirin is known to affect various parts inside human body, ranging from lung to spermatogenesis. FSIP1, also known as HDS10, is a recently discovered gene that encodes fibrous sheath interacting protein 1, and is regulated by amyloid beta precursor protein (APP). Recently, it has been reported that a peptide derived from APP is cleaved by α disintegrin and metalloproteinase 33 (ADAM33), which is an asthma susceptibility gene. It has also been known that the FSIP1 gene is expressed in airway epithelium. Objectives: Aim of this study is to find out whether FSIP1 polymorphisms affect the onset of AIA in Korean population, since it is known that AIA is genetically affected by various genes. Methods: We conducted association study between 66 single nucleotide polymorphisms (SNPs) of the FSIP1 gene and AIA in total of 592 Korean subjects including 163 AIA and 429 aspirin-tolerant asthma (ATA) patients. Associations between polymorphisms of FSIP1 and AIA were analyzed with sex, smoking status, atopy, and body mass index (BMI) as covariates. Results: Initially, 18 SNPs and 4 haplotypes showed associations with AIA. However, after correcting the data for multiple testing, only one SNP showed an association with AIA (corrected P-value = 0.03, OR = 1.63, 95% CI = 1.23-2.16), showing increased susceptibility to AIA compared with that of ATA cases. Our findings suggest that FSIP1 gene might be a susceptibility gene for aspirin intolerance in asthmatics. Conclusion: Although our findings did not suggest that SNPs of FSIP1 had an effect on the reversibility of lung function abnormalities in AIA patients, they did show significant evidence of association between the variants in FSIP1 and AIA occurrence among asthmatics in a Korean population.
- 1 June 2010
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 10  (1) , 34
Open AccessPositive Association between Aspirin-Intolerant Asthma and Genetic Polymorphisms of FSIP1: a Case-Case Study
Background: Aspirin-intolerant asthma (AIA), which is caused by non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, causes lung inflammation and reversal bronchi reduction, leading to difficulty in breathing. Aspirin is known to affect various parts inside human body, ranging from lung to spermatogenesis. FSIP1, also known as HDS10, is a recently discovered gene that encodes fibrous sheath interacting protein 1, and is regulated by amyloid beta precursor protein (APP). Recently, it has been reported that a peptide derived from APP is cleaved by α disintegrin and metalloproteinase 33 (ADAM33), which is an asthma susceptibility gene. It has also been known that the FSIP1 gene is expressed in airway epithelium. Objectives: Aim of this study is to find out whether FSIP1 polymorphisms affect the onset of AIA in Korean population, since it is known that AIA is genetically affected by various genes. Methods: We conducted association study between 66 single nucleotide polymorphisms (SNPs) of the FSIP1 gene and AIA in total of 592 Korean subjects including 163 AIA and 429 aspirin-tolerant asthma (ATA) patients. Associations between polymorphisms of FSIP1 and AIA were analyzed with sex, smoking status, atopy, and body mass index (BMI) as covariates. Results: Initially, 18 SNPs and 4 haplotypes showed associations with AIA. However, after correcting the data for multiple testing, only one SNP showed an association with AIA (corrected P-value = 0.03, OR = 1.63, 95% CI = 1.23-2.16), showing increased susceptibility to AIA compared with that of ATA cases. Our findings suggest that FSIP1 gene might be a susceptibility gene for aspirin intolerance in asthmatics. Conclusion: Although our findings did not suggest that SNPs of FSIP1 had an effect on the reversibility of lung function abnormalities in AIA patients, they did show significant evidence of association between the variants in FSIP1 and AIA occurrence among asthmatics in a Korean population.
- Open Access
- 20 October 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10  (1) , 106
Genetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization
Background: We previously demonstrated that single nucleotide polymorphism (SNP) and haplotypes were associated with aspirin hypersensitivity in asthmatics. We investigated the genetic effects of the SNPs and haplotypes on the expression of theCysLTR2gene.Methods: We measured CysLTR2 protein and mRNA expression in EB virus-infected B cell lines from asthmatics havinght1+/+andht2+/+. A gel retardation assay was used to identify nuclear protein binding to the c.-819 promoter site. The function of promoter and 3'-UTR were assessed using pGL3 luciferase and pEGFP reporter system, respectively.Results: We found that the expression of CysLTR2 protein was higher in B cell lines of asthmatics havinght2+/+than in those havinght1+/+. PMA/ionomycin induced higher mRNA expression of CysLTR2 in B cell lines fromht2+/+asthmatics than those fromht1+/+asthmatics. A nuclear protein from the B cell lines showed stronger DNA binding affinity with a probe containingc.-819T thanone containingc.-819G. The luciferase activity of thec.-819Ttype ofCysLTR2promoter was higher than that of thec.-819Gtype. EGFP expression was higher in the EGFP-c.2078T3'-UTR fusion construct than in thec.2078Cconstruct.Conclusion: The sequence variants ofCysLTR2may affect its transcription and the stability of its mRNA, resulting in altered expression of CysLTR2 protein, which in turn causes some asthmatics to be susceptible to aspirin hypersensitivity.
- 20 October 2009
- Published by Springer Nature in BMC Medical Genetics
- Vol. 10  (1) , 106
Open AccessGenetic effect of CysLTR2 polymorphisms on its mRNA synthesis and stabilization
Background: We previously demonstrated that single nucleotide polymorphism (SNP) and haplotypes were associated with aspirin hypersensitivity in asthmatics. We investigated the genetic effects of the SNPs and haplotypes on the expression of theCysLTR2gene.Methods: We measured CysLTR2 protein and mRNA expression in EB virus-infected B cell lines from asthmatics havinght1+/+andht2+/+. A gel retardation assay was used to identify nuclear protein binding to the c.-819 promoter site. The function of promoter and 3'-UTR were assessed using pGL3 luciferase and pEGFP reporter system, respectively.Results: We found that the expression of CysLTR2 protein was higher in B cell lines of asthmatics havinght2+/+than in those havinght1+/+. PMA/ionomycin induced higher mRNA expression of CysLTR2 in B cell lines fromht2+/+asthmatics than those fromht1+/+asthmatics. A nuclear protein from the B cell lines showed stronger DNA binding affinity with a probe containingc.-819T thanone containingc.-819G. The luciferase activity of thec.-819Ttype ofCysLTR2promoter was higher than that of thec.-819Gtype. EGFP expression was higher in the EGFP-c.2078T3'-UTR fusion construct than in thec.2078Cconstruct.Conclusion: The sequence variants ofCysLTR2may affect its transcription and the stability of its mRNA, resulting in altered expression of CysLTR2 protein, which in turn causes some asthmatics to be susceptible to aspirin hypersensitivity.
- Open Access
- 1 January 2009
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 24  (Suppl 2) , S267-S270
Guideline of the Korean Academy of Medical Sciences for Assessing Respiratory Impairment
Kim H, et al. J Korean Med Sci. 2009 May;24(Suppl 2):S267-S270. http://dx.doi.org/10.3346/jkms.2009.24.S2.S267
- 1 January 2009
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 24  (Suppl 2) , S267-S270
Open AccessGuideline of the Korean Academy of Medical Sciences for Assessing Respiratory Impairment
Kim H, et al. J Korean Med Sci. 2009 May;24(Suppl 2):S267-S270. http://dx.doi.org/10.3346/jkms.2009.24.S2.S267
- Open Access
- 1 January 2009
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 66  (2) , 98-103
Clinical Features of Pulmonary Langerhans Cell Histiocytosis in Korea
Kim C, et al. Tuberc Respir Dis. 2009 Feb;66(2):98-103. http://dx.doi.org/10.4046/trd.2009.66.2.98
- 1 January 2009
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 66  (2) , 98-103
Open AccessClinical Features of Pulmonary Langerhans Cell Histiocytosis in Korea
Kim C, et al. Tuberc Respir Dis. 2009 Feb;66(2):98-103. http://dx.doi.org/10.4046/trd.2009.66.2.98
- 23 October 2008
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 24  (12) , 3571-3582
Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea
In the Asia-Pacific region there is a general preference for prescribing oral over inhaled medications for the treatment of asthma. This study compared inhaled salmeterol/fluticasone propionate therapy (SFC) with physician-determined current care (CC) in the management of persistent asthma in Korea. Adult patients with a documented history of reversibility in FEV(1) (>or= 12%) or PEF (>or= 15%), were randomised in a 2:1 ratio to unblinded treatment with SFC (50/250 microg bd or 50/500 microg bd) via Diskus (N = 284) or CC (N = 140) for 52 weeks. Morning peak expiratory flow (PEF) (primary endpoint), exacerbations, asthma symptoms and patient-reported outcome measures were recorded. GSK study number:100614. At baseline, mean morning PEF in the SFC and CC group was 374 and 401 L/min respectively. The adjusted mean morning PEF at 52 weeks was 423 +/- 3 and 396 +/- 4 L/min for SFC and CC respectively (treatment difference of 27 +/- 5 in favour of SFC; 95% CI 17, 37; p < 0.0001). The mean rate of exacerbations over 52 weeks was significantly lower in the SFC group (SFC/CC odds ratio 0.57; 95% CI 0.44, 0.74; p < 0.0001). Treatment with SFC also resulted in a significantly greater improvement in asthma symptoms, in the number of patients assessed to have well controlled asthma (Asthma Control Test score >or= 20), and in a clinically significant improvement in overall Quality of Life. The incidence of adverse events was low and similar between the two groups and events were of the type expected in this population. The results of this open-label, randomised study showed that SFC provided greater asthma control than CC in the management of persistent asthma.
- 23 October 2008
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 24  (12) , 3571-3582
Comparison of the clinical efficacy and safety of salmeterol/fluticasone propionate versus current care in the management of persistent asthma in Korea
In the Asia-Pacific region there is a general preference for prescribing oral over inhaled medications for the treatment of asthma. This study compared inhaled salmeterol/fluticasone propionate therapy (SFC) with physician-determined current care (CC) in the management of persistent asthma in Korea. Adult patients with a documented history of reversibility in FEV(1) (>or= 12%) or PEF (>or= 15%), were randomised in a 2:1 ratio to unblinded treatment with SFC (50/250 microg bd or 50/500 microg bd) via Diskus (N = 284) or CC (N = 140) for 52 weeks. Morning peak expiratory flow (PEF) (primary endpoint), exacerbations, asthma symptoms and patient-reported outcome measures were recorded. GSK study number:100614. At baseline, mean morning PEF in the SFC and CC group was 374 and 401 L/min respectively. The adjusted mean morning PEF at 52 weeks was 423 +/- 3 and 396 +/- 4 L/min for SFC and CC respectively (treatment difference of 27 +/- 5 in favour of SFC; 95% CI 17, 37; p < 0.0001). The mean rate of exacerbations over 52 weeks was significantly lower in the SFC group (SFC/CC odds ratio 0.57; 95% CI 0.44, 0.74; p < 0.0001). Treatment with SFC also resulted in a significantly greater improvement in asthma symptoms, in the number of patients assessed to have well controlled asthma (Asthma Control Test score >or= 20), and in a clinically significant improvement in overall Quality of Life. The incidence of adverse events was low and similar between the two groups and events were of the type expected in this population. The results of this open-label, randomised study showed that SFC provided greater asthma control than CC in the management of persistent asthma.
- Open Access
- 1 January 2008
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 23  (1) , 134-137
Cigarette Smoking-Induced Acute Eosinophilic Pneumonia: A Case Report Including a Provocation Test
Bok GH, et al. J Korean Med Sci. 2008 Feb;23(1):134-137. http://dx.doi.org/10.3346/jkms.2008.23.1.134
- 1 January 2008
- Published by Korean Academy of Medical Sciences in Journal of Korean Medical Science
- Vol. 23  (1) , 134-137
Open AccessCigarette Smoking-Induced Acute Eosinophilic Pneumonia: A Case Report Including a Provocation Test
Bok GH, et al. J Korean Med Sci. 2008 Feb;23(1):134-137. http://dx.doi.org/10.3346/jkms.2008.23.1.134